← All companies
CRSP annual net income
CRISPR Therapeutics AG
CRSP - CIK 0001674416
Market cap$4.80 B
Rank#1436
SEC filings837
CRISPR Therapeutics AG net income by year
CRISPR Therapeutics AG (CRSP) reported net income of -$581.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
CRSP net income 2014-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$581.60M | -58.8% |
| FY 2024 | -$366.25M | -138.4% |
| FY 2023 | -$153.61M | +76.4% |
| FY 2022 | -$650.17M | -272.2% |
| FY 2021 | $377.66M | +208.3% |
| FY 2020 | -$348.87M | -621.8% |
| FY 2019 | $66.86M | +140.5% |
| FY 2018 | -$164.98M | -141.4% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does CRISPR Therapeutics AG make?
CRISPR Therapeutics AG (CRSP) reported net income of -$581.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has CRISPR Therapeutics AG's net income changed over time?
Between fiscal 2014 and fiscal 2025, CRISPR Therapeutics AG's net income declined from -$7.01M to -$581.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.